på 5 millioner IE/ m2 og 10 millioner IE indgivet subkutant, ved doser på 5 millioner IE/ m2 indgivet intramuskulært og som en 30 minutters intravenøs infusion.
ge 5.2 Pharmacokinetic properties lon The pharmacokinetics of Viraferon were studied in healthy volunteers following single 5 million IU/ m2 and 10 million IU doses administered subcutaneously, at 5 million IU/ m2 administered intramuscularly and as a 30-minute intravenous infusion.